Bayesian Capital Management’s Teladoc Health TDOC Stock Holding History

Bayesian Capital Management’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$213K	Buy	+25,100	New	+$167K	0.14%	198
2025 Q1	–	Sell	-18,683	Closed	-$170K	–	954
2024 Q4	$170K	Buy	+18,683	New	+$180K	0.02%	583
2023 Q4	–	Sell	-154,702	Closed	-$2.88M	–	1021
2023 Q3	$2.88M	Buy	154,702 +137,000	+774%	+$3.2M	0.33%	76
2023 Q2	$448K	Sell	17,702 -28,200	-61%	-$710K	0.05%	432
2023 Q1	$1.19M	Buy	+45,902	New	+$1.23M	0.15%	207
2022 Q3	–	Sell	-21,800	Closed	-$724K	–	1011
2022 Q2	$724K	Buy	21,800 +4,200	+24%	+$178K	0.13%	234
2022 Q1	$1.27M	Buy	+17,600	New	+$1.27M	0.19%	156
2020 Q3	–	Sell	-19,000	Closed	-$3.63M	–	691
2020 Q2	$3.63M	Buy	19,000 +6,800	+56%	+$1.19M	0.8%	14
2020 Q1	$1.89M	Buy	+12,200	New	+$1.42M	0.41%	40
2019 Q4	–	Sell	-7,737	Closed	-$524K	–	745
2019 Q3	$524K	Buy	+7,737	New	+$509K	0.1%	268

Other funds holding TDOC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return

Bayesian Capital Management's TDOC Position: Q2 2026 in Review

Bayesian Capital Management opened a new position in Teladoc Health (TDOC) in Q2 2026: 25,100 shares worth $213K. The stake represents 0.14% of the portfolio and ranks #198 among its holdings. This is a return to the name: Bayesian Capital Management previously reported a position in TDOC as recently as Q4 2024.

Bayesian Capital Management first reported a position in TDOC in Q3 2019 and has held it in 10 quarters since. The position peaked at $3.63M in Q2 2020. 348 funds tracked by Wall St. Rank hold TDOC as of Q2 2026.

Bayesian Capital Management held 25,100 shares of Teladoc Health worth $213K as of Q2 2026.
Teladoc Health was a new Bayesian Capital Management position in Q2 2026.
Teladoc Health made up 0.14% of Bayesian Capital Management's portfolio in Q2 2026, its #198 holding.
Bayesian Capital Management first reported a position in Teladoc Health in Q3 2019 and has held it in 10 quarters since.
Bayesian Capital Management's Teladoc Health position peaked at $3.63M in Q2 2020.
348 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2026.

Based on Bayesian Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.